Mon • Jun
3

Monday, June 3, 2019

6:00PM-8:30PM

Venue

The New York Academy of Medicine, 1216 Fifth Avenue at 103rd Street, New York, NY 10029

Sponsored by:

The Academy Section on Dermatology

Cost

Free, advance registration required

Join us for this annual event that showcases top residents from Dermatology programs in the greater New York/New Jersey area presenting their original clinical and scientific research. Prizes are awarded to the top presenters.

Audience: This event is only open to Dermatology residents, fellows and other professionals in the field of dermatology.

Poster Presenters

Ali Hadi, MD
Icahn School of Medicine at Mount Sinai
Comorbid Diseases of Vitiligo: A ten-year cross-sectional retrospective study of an urban United States population

Peter Hashim, MD, MHS
Icahn School of Medicine at Mount Sinai
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, placebo-controlled trial

Grace Kimmel, MD
Icahn School of Medicine at Mount Sinai
Brodalumab in the treatment of moderate-to-severe psoriasis in patients who have previously failed treatment with anti-interleukin-17A therapies

Tian Zhu, MD
Albert Einstein College of Medicine/Montefiore
Epithelial barrier dysfunctions in atopic dermatitis: a skin–gut–lung model linking microbiome alteration and immune dysregulation

Shira Wieder, MD
Icahn School of Medicine at Mount Sinai
Atypical Intraepidermal Melanocytic Proliferation – But What Should We Tell Our Patients?

Michelle Min, MD, MS
Icahn School of Medicine at Mount Sinai
Cell Cycle Activators and Tumor Suppressors that Correlate with Melanoma Progression

Oral Presenters
Elyse Love, MD
NYU School of Medicine
The Prevalance of Psychiatric Disorders in Patients with Moderate to Severe Acne

Daniel Mazori, MD
SUNY Downstate Medical Center
Posterior auricular cutaneous reaction to infliximab in a young man with Crohn’s disease

Myron Zhang, MD
Weill Cornell Medicine/NewYork – Presbyterian
Predictors of 30-day Readmission in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Mojgan Hossinipour, DO
St. Barnabas Hospital
Use of Triamcinolone Acetate to Reduce the Inflammation Associated with Kybella Injection

Jessica Garelik, DO
Albert Einstein College of Medicine/Montefiore Medical Center
High-dose intralesional triamcinolone: a novel adjuvant therapy for acute inflammatory lesions of hidradenitis suppurativa

Ann John, MD
Rutgers University Robert Wood Johnson Medical School
The Tam Formula: A New Treatment for Melasma

Aaron Farberg, MD
Icahn School of Medicine at Mount Sinai
Development of a multi-gene expression profile for recurrence risk prediction in cutaneous squamous cell carcinoma

Chelsea Cooper, MD
Columbia University Medical Center
A clinical, histopathologic, and outcome study of melanonychia striata in childhood